Aims & Scope

Online ISSN: 2766-2705 | Continuous Publication | Current Volume: 1

Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure across the leading media platforms in the industry.

Re:GEN Open is dedicated to publishing open access advances across all aspects of basic and translational biomedical research, organized into the following core areas:

  • Basic Biomedical Research
  • Translational Biomedical Research     
  • Drug Development                 
  • Cancer Research
  • Regenerative Medicine                      
  • Cell and Gene Therapy            
  • Infectious Disease      
  • Synthetic and Systems Biology            

Editorial Board


Vasu Punj, Ph.D.
University of Southern California
Los Angeles, CA, USA

Executive Editor

Kevin Davies, Ph.D.
Mary Ann Liebert, Inc., publishers
New Rochelle, NY, USA

Editorial Advisory Board

Arthur M. Feldman, M.D., Ph.D.
Temple University
Philadelphia, PA, USA

Alexander V. Ljubimov, Ph.D., FARVO, FRSM
Cedars-Sinai Medical Center
Los Angeles, CA, USA

Jeffrey McCullough, M.D
University of Minnesota
Minneapolis, MN, USA

Sharad Verma, Ph.D.*
National Cancer Institute
Rockville, MD, USA

 (*Serving in his personal capacity)

Wolfgang Wagner, Ph.D.
RWTH Aachen University Medical School
Aachen, Germany

Associate Editors

Cell and Gene Therapy

Jianzhong Ai, Ph.D.
West China Hospital
Sichuan University
Chengdu, Sichuan, China

Alireza Dolatshahi-Pirouz, Ph.D.
Technical University of Denmark
Kgs Lyngby Denmark

Andy Tay, Ph.D.
National University of Singapore
Singapore, Singapore

Basic Biomedical Research

Ambak K Rai, Ph.D.
Motilal Nehru National Institute of Technology Allahabad
Prayagraj, India

Tungki Pratama Umar, M.D.
Sriwijaya University
Palembang, Indonesia

Synthetic and Systems Biology

Xiaoqiu Huang, Ph.D.
Iowa State University
Ames, IA, USA

Khanh N. Q. Le, Ph.D.
Taipei Medical University
Taipei, Taiwan

Binh P. Nguyen, PhD
Victoria University of Wellington
Wellington, New Zealand

Ché S. Pillay, Ph.D.
University of KwaZulu-Natal
Pietermaritzburg, South Africa

Rongling Wu, Ph.D.
The Pennsylvania State University
Hershey, PA, USA

Zongliang Yue, Ph.D.
The University of Alabama at Birmingham
Birmingham, AL, USA

Hufeng Zhou, Ph.D.
Harvard T.H. Chan School of Public Health
Boston, MA, USA

Drug Development

Enam Khalil, Ph.D.
The University of Jordan
Amman, Jordan

Bruce J. Melancon, Ph.D.
Vanderbilt University
Nashville, TN, USA

Fai Poon, Ph.D.
QuaCell Biotechnology Co., Ltd
Zhongshan, China

Surya P. Singh Ph.D.
Banaras Hindu University
Varanasi, India

Translational Biomedical Research

Marcel M. Daadi, Ph.D.
Texas Biomedical Research Institute
San Antonio, TX, USA

Frederique Ponchel, Ph.D.
The University of Leeds
Leeds, United Kingdom

Jobin Varkey, Ph.D. 
University of Southern California
Los Angeles, CA, USA

Cancer Research

Richard J. Ablin, PhD, DSc
The University of Arizona Health Sciences
Tucson, AZ, USA

Pedro J. C. Rondot Radío, M.D.
University of Buenos Aires
Buenos Aires, Argentina

Reinhard Schulte, M.D.
Loma Linda University
Loma Linda, CA, USA

Infectious Diseases

Min Wu, Ph.D
University of North Dakota
Grand Forks, ND, USA

Regenerative Medicine

Patrizia Dell'Era, Ph.D.
University of Brescia
Brescia, Italy

Yohei Hayashi, Ph.D.
BioResource Research Center, RIKEN
Tsukuba, Ibaraki, Japan

Suzanne Kadereit, Ph.D.
University Konstanz
Konstanz, Germany